{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:31:44Z","timestamp":1778041904567,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.clgc.2026.102520","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:48:59Z","timestamp":1771001339000},"page":"102520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Predictors of Early and Late Oncologic Failure After Primary Prostate Cryoablation for Localized Prostate Cancer"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-5944-5637","authenticated-orcid":false,"given":"Salvatore","family":"Basile","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Misuraca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Mastroianni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"D'Annunzio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocco Simone","family":"Flammia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Tuderti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Iannuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Cartolano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7315-7520","authenticated-orcid":false,"given":"Riccardo","family":"Capecchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo Maria","family":"Bove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavia","family":"Proietti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Tufano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Lugnani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7586-4132","authenticated-orcid":false,"given":"Umberto","family":"Anceschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Simone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clgc.2026.102520_bib0001","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41391-022-00501-0","article-title":"Focal prostate cancer therapy in the era of multiparametric MRI: a review of options and outcomes","volume":"26","author":"Heard","year":"2023","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"6","key":"10.1016\/j.clgc.2026.102520_bib0002","doi-asserted-by":"crossref","first-page":"712.e1","DOI":"10.1016\/j.clgc.2023.04.013","article-title":"An update on focal therapy for prostate cancer","volume":"21","author":"Ayerra Perez","year":"2023","journal-title":"Clin Genitourin Cancer"},{"issue":"5","key":"10.1016\/j.clgc.2026.102520_bib0003","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s11255-023-03519-y","article-title":"Treatment of localized prostate cancer in elderly patients: the role of partial cryoablation","volume":"55","author":"Selvaggio","year":"2023","journal-title":"Int Urol Nephrol"},{"issue":"11","key":"10.1016\/j.clgc.2026.102520_bib0004","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1111\/j.1464-410X.2011.10578.x","article-title":"Focal cryotherapy for localized prostate cancer: a report from the National Cryo On-Line Database (COLD) Registry","volume":"109","author":"Ward","year":"2012","journal-title":"BJU Int"},{"issue":"7","key":"10.1016\/j.clgc.2026.102520_bib0005","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1089\/end.2018.0809","article-title":"Comprehensive evaluation of focal therapy complications in prostate cancer: a standardized methodology","volume":"33","author":"Bakavicius","year":"2019","journal-title":"J Endourol"},{"issue":"11","key":"10.1016\/j.clgc.2026.102520_bib0006","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/iju.14991","article-title":"Focal therapy of localized prostate cancer","volume":"29","author":"Fujihara","year":"2022","journal-title":"Int J Urol"},{"issue":"12","key":"10.1016\/j.clgc.2026.102520_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14122988","article-title":"mpMRI-US fusion-guided targeted cryotherapy in patients with primary localized prostate cancer: a prospective analysis of oncological and functional outcomes","volume":"14","author":"Fern\u00e1ndez-Pascual","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.clgc.2026.102520_bib0008","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/iju.13857","article-title":"Biochemical and magnetic resonance image response in targeted focal cryotherapy to ablate targeted biopsy-proven index lesion of prostate cancer","volume":"26","author":"Inoue","year":"2019","journal-title":"Int J Urol"},{"issue":"1","key":"10.1016\/j.clgc.2026.102520_bib0009","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.eururo.2021.08.005","article-title":"An updated systematic review on focal therapy in localized prostate cancer: what has changed over the past 5 years?","volume":"81","author":"Hopstaken","year":"2022","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.clgc.2026.102520_bib0010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/curroncol32010015","article-title":"Focal therapy for prostate cancer: recent advances and insights","volume":"32","author":"Lasorsa","year":"2024","journal-title":"Curr Oncol"},{"key":"10.1016\/j.clgc.2026.102520_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2021.696242","article-title":"Focal therapy for prostate cancer: complications and their treatment","volume":"8","author":"Rakauskas","year":"2021","journal-title":"Front Surg"},{"issue":"1","key":"10.1016\/j.clgc.2026.102520_bib0012","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.eururo.2018.12.030","article-title":"Early-medium-term outcomes of primary focal cryotherapy to treat nonmetastatic clinically significant prostate cancer from a prospective multicentre registry","volume":"76","author":"Shah","year":"2019","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.clgc.2026.102520_bib0013","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1089\/end.2016.0830","article-title":"Propensity score-matched comparison of partial to whole-gland cryotherapy for intermediate-risk prostate cancer: an analysis of the cryo on-line data registry data","volume":"31","author":"Tay","year":"2017","journal-title":"J Endourol"},{"issue":"2","key":"10.1016\/j.clgc.2026.102520_bib0014","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/JU.0000000000000506","article-title":"Focal therapy for localized prostate cancer with either high intensity focused ultrasound or cryoablation: a single institution experience","volume":"203","author":"Tourinho-Barbosa","year":"2020","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.clgc.2026.102520_bib0015","doi-asserted-by":"crossref","first-page":"26","DOI":"10.21037\/atm-21-5033","article-title":"Focal cryotherapy for prostate cancer: a contemporary literature review","volume":"11","author":"Kotamarti","year":"2023","journal-title":"Ann Transl Med"},{"issue":"6","key":"10.1016\/j.clgc.2026.102520_bib0016","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1097\/JU.0000000000000456","article-title":"Hemigland cryoablation of localized low, intermediate and high risk prostate cancer: oncologic and functional outcomes at 5 years","volume":"202","author":"Oishi","year":"2019","journal-title":"J Urol"},{"issue":"8","key":"10.1016\/j.clgc.2026.102520_bib0017","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.clon.2013.05.002","article-title":"Focal therapy for prostate cancer: rationale and treatment opportunities","volume":"25","author":"Kasivisvanathan","year":"2013","journal-title":"Clin Oncol"},{"issue":"3","key":"10.1016\/j.clgc.2026.102520_bib0018","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41391-024-00911-2","article-title":"Established focal therapy\u2014HIFU, IRE, or cryotherapy\u2014Where are we now?\u2014A systematic review and meta-analysis","volume":"28","author":"Tay","year":"2025","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"2","key":"10.1016\/j.clgc.2026.102520_bib0019","doi-asserted-by":"crossref","first-page":"e477","DOI":"10.1016\/j.clgc.2017.10.009","article-title":"Associations between prostate volume and oncologic outcomes in men undergoing focal cryoablation of the prostate","volume":"16","author":"Elshafei","year":"2018","journal-title":"Clin Genitourin Cancer"},{"issue":"3","key":"10.1016\/j.clgc.2026.102520_bib0020","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.eururo.2020.05.018","article-title":"Standardized nomenclature and surveillance methodologies after focal therapy and partial gland ablation for localized prostate cancer: an international multidisciplinary consensus","volume":"78","author":"Lebastchi","year":"2020","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.clgc.2026.102520_bib0021","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3390\/jpm13060978","article-title":"Single-setting 3D MRI\/US-guided frozen sectioning and cryoablation of the index lesion: mid-term oncologic and functional outcomes from a pilot study","volume":"13","author":"Misuraca","year":"2023","journal-title":"J Pers Med"},{"issue":"3","key":"10.1016\/j.clgc.2026.102520_bib0022","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.euf.2025.01.004","article-title":"Long-term oncological outcomes of partial gland cryoablation of localized prostate cancer with median follow-up of 7 years: a single-institution experience","volume":"11","author":"Deivasigamani","year":"2025","journal-title":"Eur Urol Focus"},{"issue":"2","key":"10.1016\/j.clgc.2026.102520_bib0023","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00345-017-2130-5","article-title":"PSA kinetics following primary focal cryotherapy (hemiablation) in organ-confined prostate cancer patients","volume":"36","author":"Kongnyuy","year":"2018","journal-title":"World J Urol"},{"issue":"3","key":"10.1016\/j.clgc.2026.102520_bib0024","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.euf.2021.04.008","article-title":"Long-term outcomes of focal cryotherapy for low- to intermediate-risk prostate cancer: results and matched pair analysis with active surveillance","volume":"8","author":"Marra","year":"2022","journal-title":"Eur Urol Focus"},{"issue":"6","key":"10.1016\/j.clgc.2026.102520_bib0025","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.eururo.2023.06.013","article-title":"Primary whole-gland ablation for the treatment of clinically localized prostate cancer: a Focal Therapy Society Best Practice statement","volume":"84","author":"Deivasigamani","year":"2023","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.clgc.2026.102520_bib0026","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/s41391-024-00907-y","article-title":"Identifying the best candidate for focal therapy: a comprehensive review","volume":"28","author":"Ghoreifi","year":"2025","journal-title":"Prostate Cancer Prostatic Dis"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767326000200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767326000200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T14:53:29Z","timestamp":1773672809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767326000200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1558767326000200"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2026.102520","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of Early and Late Oncologic Failure After Primary Prostate Cryoablation for Localized Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2026.102520","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102520"}}